scholarly journals Infection control in households of drug-resistant tuberculosis patients co-infected with HIV in Mumbai, India

2014 ◽  
Vol 4 (1) ◽  
pp. 35-41 ◽  
Author(s):  
T. Albuquerque ◽  
P. Isaakidis ◽  
M. Das ◽  
P. Saranchuk ◽  
A. Andries ◽  
...  
Keyword(s):  
Infection Control ◽  
Drug Resistant ◽  
Drug Resistant Tuberculosis ◽  
Tuberculosis Patients ◽  
Resistant Tuberculosis

scholarly journals Infection control in hospitals managing drug-resistant tuberculosis in Pakistan: how are we doing?

2017 ◽  
Vol 7 (1) ◽  
pp. 26-31 ◽  
Author(s):  
Y. Waheed ◽  
M. A. Khan ◽  
R. Fatima ◽  
A. Yaqoob ◽  
A. Mirza ◽  
...  
Keyword(s):  
Infection Control ◽  
Drug Resistant ◽  
Drug Resistant Tuberculosis ◽  
Resistant Tuberculosis

Optimized loading dose strategies for bedaquiline when restarting interrupted drug-resistant tuberculosis treatment

2022 ◽  
Author(s):  
Simon E Koele ◽  
Stijn W van Beek ◽  
Gary Maartens ◽  
James C. M. Brust ◽  
Elin M Svensson
Keyword(s):  
Treatment Interruption ◽  
Loading Dose ◽  
Drug Resistant ◽  
Time Curve ◽  
Resistance Development ◽  
Drug Resistant Tuberculosis ◽  
Tuberculosis Patients ◽  
Resistant Tuberculosis ◽  
Starting Point ◽  
One Year

Interruption of treatment is common in drug-resistant tuberculosis patients. Bedaquiline has a long terminal half-life therefore, restarting after an interruption without a loading dose could increase the risk of suboptimal treatment outcome and resistance development. We aimed to identify the most suitable loading dose strategies for bedaquiline restart after an interruption. A model-based simulation study was performed. Pharmacokinetic profiles of bedaquiline and its metabolite M2 (associated with QT-prolongation) were simulated for 5000 virtual patients for different durations and starting points of treatment interruption. Weekly bedaquiline area under the concentration-time curve (AUC) and M2 maximum concentration (Cmax) deviation before interruption and after reloading were assessed to evaluate the efficacy and safety respectively of the reloading strategies. Bedaquiline weekly AUC and M2 Cmax deviation were mainly driven by the duration of interruption and only marginally by the starting point of interruption. For interruptions with a duration shorter than two weeks, no new loading dose is needed. For interruptions with durations between two weeks and one month, one month and one year, and longer than one year, reloading periods of three days, one week, and two weeks, respectively, are recommended. This reloading strategy results in an average bedaquiline AUC deviation of 1.88% to 5.98% compared with -16.4% to -59.8% without reloading for interruptions of two weeks and one year respectively, without increasing M2 Cmax. This study presents easy-to-implement reloading strategies for restarting a patient on bedaquiline treatment after an interruption.

scholarly journals Linezolid-Associated Optic Neuropathy in Drug-Resistant Tuberculosis Patients in Mumbai, India

PLoS ONE ◽  
2016 ◽  
Vol 11 (9) ◽  
pp. e0162138 ◽  
Author(s):  
Salil Mehta ◽  
Mrinalini Das ◽  
Chinmay Laxmeshwar ◽  
Sylvie Jonckheere ◽  
Sein Sein Thi ◽  
...  
Keyword(s):  
Optic Neuropathy ◽  
Drug Resistant ◽  
Drug Resistant Tuberculosis ◽  
Tuberculosis Patients ◽  
Resistant Tuberculosis
Sign in / Sign up

Export Citation Format

Share Document